New gene therapy that can reverse heart failure developed
Washington: Scientists have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models.
The research from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai is the final study phase before human clinical trials can begin testing SUMO-1 gene therapy. SUMO-1 is a gene that is "missing in action" in heart failure patients.
"SUMO-1 gene therapy may be one of the first treatments that can actually shrink enlarged hearts and significantly improve a damaged heart's life-sustaining function,. We are very eager to test this gene therapy in our patients suffering from severe heart failure," the study's senior investigator Roger J. Hajjar, MD, Director of the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai and the Arthur and Janet C. Ross Professor of Medicine at Mount Sinai said.
The first trial, named CUPID, is in its final phases of testing SERCA2 gene therapy. Phase 1 and phase 2a trial results were positive, demonstrating substantial improvement in clinical events.
In that trial, a gene known as SERCA2 is delivered via an inert virus - a modified virus without infectious particles. SERCA2 is a gene that produces an enzyme critical to the proper pumping of calcium out of cells. In heart failure, SERCA2 is dysfunctional, forcing the heart to work harder and in the process, to grow larger.
The virus carrying SERCA2 is delivered through the coronary arteries into the heart during a cardiac catheterization procedure. Studies show only a one-time gene therapy dose is needed to restore healthy SERCA2a gene production of its beneficial enzyme.
In large animal models of heart failure, the researchers found that gene therapy delivery of high dose SUMO-1 alone, as well as SUMO-1 and SERCA2 together, result in stronger heart contractions, better blood flow, and reduced heart volumes, compared to just SERCA2 gene therapy alone.
The study is published in journal Science Translational Medicine.
More from India
More from World
More from Sports
More from Entertaiment
- Zee Media Exclusive: Kangana, Madhavan talk about their film 'Tanu Weds Manu Returns'
- DNA: Harmful chemicals found in Maggi, Nestle India still in denial mode
- CM Kejriwal shortlists 39 'unwanted' IAS officers in Delhi
- Rajasthan: Gujjars revive reservation agitation, block rail track
- DNA: Modi-led NDA govt's hits and misses in one year
- J Jayalalithaa sworn-in as Chief Minister of Tamil Nadu
- Zee Media Exclusive interview with Congress leader Kamal Nath
- Mumbai: One injured in shootout at Film City
- ISIS to buy first nuclear weapon from Pak?
- Mumbai: CCTV captures assailant with gun at Film City
- Dr Subhash Chandra Show: Aspiring for more than what you have!
- BJP now central pole of Indian politics: Arun Jaitley
- Maharashtra FDA sends Maggi noodles for lab testing
- Mathura SSP receives death threat letter, message for PM Modi
- See what can Maggi do to your health!
- IPL 2015, Qualifier 2: CSK vs RCB - As it happened...
- India to soon have its own space shuttle!
- PM Narendra Modi graces Digvijay Singh's son wedding reception
- Rahul Gandhi to pressurise govt to act on one-rank-one-pension issue
- Goa Board SSC Exam Results 2015 announced
- ISIS close to buying nuclear weapon from Pakistan?
- CBSE 12th Results 2015: CBSE Board Cbse.nic.in & cbseresults.nic class 12th XII board exam Results 2015 date announced
- Manohar Parrikar visits forward areas along LoC, reviews security situation
- Businessman shot next to Amitabh Bachchan's shooting location in Mumbai Film City
- There will be no delay in appointing CIC, CVC: Jitendra Singh
- Credibility of Prime Minister's Office restored by BJP, says Arun Jaitley
- ISIS justifies raping slave girls, says Michelle Obama is 'worth $40'
- CBSE Board 10th Results 2015: Cbse.nic.in & Cbseresults.nic class 10th X board exam results 2015 date announced
- LIVE SCORE: 1st Test, Day 2 - England vs New Zealand
- Arvind Kejriwal to highlight AAP govt's 100 days work on Monday